Aug 6, 2026 07:32AM

Jun 18, 2026 04:32PM

Jun 3, 2026 04:09PM

Jun 1, 2026 07:31AM

Jun 1, 2026 04:40AM

May 12, 2026 09:58AM

May 7, 2026 07:17AM Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 5c ; Offers Guidance

Apr 22, 2026 06:42AM

Apr 10, 2026 01:20PM

Feb 25, 2026 03:25AM

Feb 24, 2026 07:09AM

Feb 5, 2026 05:15PM

Dec 17, 2025 02:42PM

Nov 3, 2025 07:01AM Iovance reports 26% response rate in lung cancer trial

Aug 19, 2025 06:37AM

Aug 18, 2025 04:15PM

Aug 7, 2025 04:10PM

Jul 22, 2025 08:50AM

Jul 15, 2025 04:39AM

Jul 15, 2025 03:30AM

Jul 14, 2025 07:30AM Iovance reports 49% response rate for Amtagvi in melanoma study

Jul 13, 2025 08:41AM

Jul 11, 2025 10:16AM

Jul 11, 2025 07:46AM

Jul 10, 2025 04:44PM

Jul 9, 2025 04:00PM

Jul 9, 2025 03:46PM

Jul 9, 2025 01:35PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 8, 2025 03:36PM

Jul 7, 2025 08:15PM

Jul 7, 2025 09:16AM

Jul 7, 2025 07:33AM

Jul 6, 2025 10:30AM

Jul 5, 2025 07:18AM

Jul 4, 2025 12:17PM IOVA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IOV

Jul 4, 2025 10:07AM

Jul 3, 2025 04:00PM

Jul 3, 2025 08:36AM

Jul 1, 2025 04:50PM

Jul 1, 2025 12:48PM

Jul 1, 2025 11:02AM

Jul 1, 2025 08:18AM IOVA CLASS NOTICE: Iovance Biotherapeutics Investors are Urged to Contact BFA Law before the Imminent July 14 Class Action Deadline

Jun 30, 2025 12:43PM

Jun 30, 2025 12:02PM

Jun 29, 2025 08:18AM

Jun 29, 2025 07:56AM

Jun 28, 2025 11:52AM

Jun 27, 2025 04:00PM

Jun 27, 2025 12:00PM Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Action Against Iovance Biotherapeutics, Inc. (IOVA)

Jun 27, 2025 11:30AM

446,445 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All